But my question is, what are you doing to make sure that we don't come to a place like this again, and to hold McKinsey accountable for failure to disclose what is an apparent conflict of interest?

I think it is not sufficient for us to rely on self-reporting anymore.

So I am going to follow-up with you additionally, because I am still interested in wanting an answer to whether you are going to suspend contracts, current or future contracts with McKinsey.

I led a bipartisan letter to the FDA, raising concerns about the apparent conflicts of interests surrounding the consulting firm McKinsey.

I couldn't urge more strongly for the Senate to approve, as swiftly as possible, the U.S. Attorney nominees and the Marshals nominees.

I know that Senator Moran and I both have a second round of questions that we would like to do.

We've had--sadly, we've had some high-profile suicides in New Hampshire.

Mr. President, while we all gather to acknowledge this historic day and prepare to vote to--in my case, at least--confirm Judge Jackson, I rise to bring up another issue. I rise today to urge my colleagues to pass into law commonsense…

Before I wrap up, I just want to point out what you just heard--what the American people have just heard--is talking points straight out of Big Oil's playbook. A gas tax holiday is a commonsense solution that would provide immediate relief…

Mr. President, it gives me tremendous honor and pride to offer remarks in recognition of this truly historic moment. I was first elected to the Senate in 2008 and came to Washington alongside our Nation's first African-American President…

REMS has really had two problems with, the first one was we as the generics, as we reverse engineer, need the product that we are reverse engineering to make that.

And it is using the notion of patient safety to delay the development of additional drugs that could bring down the cost.

For some medications with serious safety concerns, FDA requires manufacturers to set up risk evaluation and mitigation strategies, otherwise known as REMS programs.

Madam Speaker, I rise today in support of the Affordable Insulin Now Act, critical legislation to cap out-of-pocket costs for insulin at $35 per month. I consistently hear from Granite State families about how the rising cost of insulin is…

It is imperative for this Committee to understand what you will need from Congress to be successful.

I think that speaks to this committee's work and the need to move on those nominations as soon as we can get them.

I do not know if everybody can see this. It is kind of low, but we will hold--yeah. This is a--picture is worth a thousand words.

They have a goal of $500 billion in trade by 2025. That dwarfs what we are looking at in the United States and I think this is important to show the challenge that we face.